$CI (Cigna Corp.)

$CI {{ '2015-12-01T15:44:41+0000' | timeago}} • SEC

$CI's adjusted income from operations for 3Q15 increased by 8% from last year. This was primarily due to improved results in the Global Health Care and Group Disability and Life segments reflecting continued business growth in targeted market segments and the results of specialty health care products.

$CI {{ '2017-10-04T19:26:28+0000' | timeago}} • Announcement

$CI is attempting to reduce opioid use among its customers by 25% by 2019. Drug lists are regularly evaluated to eliminate inappropriate use of opioids. Due to this, the brand OxyContin is no longer covered as a preferred option on $CI’s group commercial drug lists effective January 1, 2018. Doctors will be advised to seek alternative options.

$CI {{ '2017-08-04T17:58:49+0000' | timeago}} • Webcast

$CI remains committed to 10-13% long-term EPS growth rate and strategic objectives to achieve $16 of EPS out in 2021. $CI would expect to grow revenue as well as earnings off of its 2017 base. $CI has a great track record of producing very strong cash flows and it expects that to continue in 2018 as well as to maintain very strong capital position.

$CI {{ '2017-08-04T17:54:34+0000' | timeago}} • Webcast

$CI sees considerable opportunities for continued growth in its Global Supplemental Benefits business, where the company serves about 13MM customer relationships and where it has grown revenue at a compounded annual rate of 18% since 2009.

$CI {{ '2017-08-04T17:53:28+0000' | timeago}} • Webcast

$CI sees meaningful growth opportunities in its targeted international markets. The company said the global health marketplace is large, complex, and changing rapidly, which provides Cigna with potential for attractive growth and ongoing value creation.

$CI {{ '2017-08-04T12:26:09+0000' | timeago}} • Infographic

$CI Cigna Earnings AlphaGraphic: Q2 2017 Highlights

$CI {{ '2017-08-04T11:09:15+0000' | timeago}} • Announcement

$CI lifted its FY17 adjusted income from operations outlook to $2.50-2.58Bil from $2.41-2.53Bil and its adjusted EPS from operations to $9.75-10.05 from $9.25-9.75. The outlook excludes the impact of additional prior year reserve development and potential effects of any future capital deployment. Total revenue growth is still expected at 3-4%.

$CI {{ '2017-08-04T11:04:09+0000' | timeago}} • Announcement

$CI's Global Supplemental Benefits results for 2Q17 continue to reflect the value created by affordable and personalized solutions delivered directly to individual consumers through a diversified set of distribution channels. Premiums and fees for 2Q17 grew 14% over the previous year quarter, reflecting continued business growth.

$CI {{ '2017-08-04T11:02:55+0000' | timeago}} • Announcement

$CI's Global Health Care delivered strong results in 2Q17, reflecting consistent performance in well-positioned growth businesses. The medical customer base at the end of 2Q17 totaled 15.7MM, an increase of 457,000 customers year to date, driven by organic growth in all of its Commercial market segments.

$CI {{ '2017-08-04T10:59:12+0000' | timeago}} • Announcement

$CI reported a jump in 2Q17 earnings driven by strong performance across its Global Health Care, Global Supplemental Benefits and Group Disability & Life segments. Net income grew to $813MM or $3.15 per share from $510MM or $1.97 per share last year. Revenue rose 4% to $10.32Bil. Adjusted EPS from operations increased to $2.91 from $1.98.

$CI {{ '2017-06-08T17:47:25+0000' | timeago}} • Announcement

$CI and $CVS announced the launch of Cigna Health WorksSM, a new collaboration that aligns Cigna-administered health benefits with CVS Pharmacy and CVS MinuteClinic retail health care services to deliver a consumer-friendly experience for Cigna self-funded employer-sponsored health plans.

$CI {{ '2017-05-05T15:12:24+0000' | timeago}} • Webcast

$CI said that the Medicaid business in Illinois, which company has planned to exit, is running at near breakeven. $CI is not characterizing this business as a major headwind or tailwind in terms of the impact. The individual commercial business is in line with expectations and margins were negative, but still better than last year, $CI said.

$CI {{ '2017-05-05T15:02:51+0000' | timeago}} • Infographic

$CI Cigna Corp. Earnings AlphaGraphics: Q1 2017 highlights

$CI {{ '2017-05-05T14:56:28+0000' | timeago}} • Webcast

Relative to Monday's Delaware chancery court review and decision, $CI said that it will not speculate the outcome or timing on that. Earlier, $CI sued $ANTM to collect the breakup fee and damages after its merger agreement with Anthem got failed.

$CI {{ '2017-05-05T14:40:05+0000' | timeago}} • Webcast

$CI stated that Medicaid is a small business for it and saw an increase in Medicaid MCR in Texas and Illinois towards the end of the last year and elevated a little bit in 1Q17. $CI does not plan to participate in the Illinois Medicaid market beyond the end of this year. The exit of that business is considered in the outlook, the company said.

$ANTM {{ '2017-05-05T14:40:01+0000' | timeago}} • Announcement

$ANTM confirmed that it is filing a petition for a writ of certiorari with the U.S. Supreme Court, seeking review of the U.S. Court of Appeals for the D.C. Circuit’s majority decision regarding the acquisition of $CI.

$CI {{ '2017-05-05T11:15:06+0000' | timeago}} • Announcement

For FY17, $CI sees FY17 consolidated adjusted income from operations at $2.41-2.53Bil, or $9.25 to $9.75 per share. The outlook excludes the impact of additional prior year reserve development and potential effects of any future capital deployment. Total revenue growth is expected at 3-4% for the year

$CI {{ '2017-05-05T11:11:14+0000' | timeago}} • Announcement

Total revenues for $CI improved 5% to $10.4Bil in 1Q17, as the health services organization's net income jumped 15% to $598MM from $519MM a year ago, Earnings rose to $2.30 per share from $2.00 a share, as Cigna ended the quarter with cash and marketable investments of $2.7Bil.

$ANTM {{ '2017-04-26T19:33:21+0000' | timeago}} • Webcast

$ANTM said that the Appeals Court verdict can go in three directions with regards to the pending $CI transaction; a) deny the company's appeal, b) accept, but in part and c) accept its appeal in its entirety. After the court's decision, the company will make the best choice. $ANTM added that it is committed to close the acquisition.

$ANTM {{ '2017-02-15T15:08:47+0000' | timeago}} • Announcement

$ANTM filed a suit seeking a temporary restraining order to enjoin $CI from terminating the merger agreement. This is in response to $CI's wrongful purported termination and lawsuit and ongoing campaign to sabotage the merger and deflect attention from its repeated willful breaches of the merger agreement.

$ANTM {{ '2017-02-15T15:07:17+0000' | timeago}} • Announcement

$ANTM filed a lawsuit in the Delaware Court of Chancery seeking a temporary restraining order to enjoin $CI from terminating, and taking any action contrary to the terms of, the Merger Agreement, specific performance compelling $CI to comply with the Merger Agreement and damages.

Recent Transcripts

DGX (Quest Diagnostics Inc.)
Thursday, October 19 2017 - 12:30pm
BK (The Bank of New York Mellon Corporation)
Thursday, October 19 2017 - 12:00pm
UNH (UnitedHealth Group Incorporated)
Tuesday, October 17 2017 - 12:45pm
ENZ (Enzo Biochem Inc.)
Thursday, September 28 2017 - 12:30pm
RAD (Rite Aid Corporation)
Thursday, September 28 2017 - 12:30pm
OMER (Omeros Corporation)
Tuesday, August 8 2017 - 8:30pm
VICL (Vical Incorporated)
Tuesday, August 8 2017 - 4:00pm
WCG (WellCare Health Plans, Inc.)
Friday, August 4 2017 - 1:00pm
CI (Cigna Corp.)
Friday, August 4 2017 - 12:00pm
TXMD (TherapeuticsMD, Inc.)
Thursday, August 3 2017 - 8:30pm
SYN (Synthetic Biologics Inc.)
Thursday, August 3 2017 - 12:30pm
AET (Aetna Inc.)
Thursday, August 3 2017 - 12:30pm
AGN (Allergan plc)
Thursday, August 3 2017 - 12:30pm
MOH (Molina Healthcare, Inc.)
Wednesday, August 2 2017 - 9:00pm
TRXC (TransEnterix, Inc.)
Wednesday, August 2 2017 - 8:30pm
HUM (Humana Inc.)
Wednesday, August 2 2017 - 1:00pm
CAH (Cardinal Health, Inc.)
Wednesday, August 2 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, August 2 2017 - 12:00pm
CNO (CNO Financial Group, Inc.)
Thursday, July 27 2017 - 3:00pm
CELG (Celgene Corporation)
Thursday, July 27 2017 - 1:00pm

AlphaGraphics you may like